Seed VC · Canada

Genesys Capital

Active

What they invest in

We invest and build companies in the high growth sectors of biotechnology, pharmaceuticals and medical technology. For over 25 years, we have been investing at the leading edge of medical innovation and have a proven track record of identifying emerging bioscience opportunities and transforming them into commercially successful companies.

Who they back

DeepTechHealthtechBiotechSeedSeries ASeries B+

Business models

biotech_therapeutics

Customer segments

Researchers

Geography

US, Canada

Recent investments

  • Fusion Pharmaceuticals
  • Flossonics Medical
  • Feldan Therapeutics

+ 3 more deals. Score your deck to see the full investment history.

We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.

Why this firm matters for fundraising founders

Genesys Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Genesys Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.

At a glance

Based in
Canada
Last known deal
Aug 2016
Portfolio last checked
Oct 6, 2026
Website
www.genesyscapital.com ↗

Other firms investing in DeepTech

See all investors

Is Genesys Capital the right fit for your deck?

Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Genesys Capital is one of them, and we'll tell you exactly where they sit in your top 100.